News & Updates

Show Multimedia Only

IBD patients who undergo coronary intervention at increased risk of MACE

08 May 2025

Patients with inflammatory bowel disease (IBD) have a higher likelihood of experiencing major adverse cardiovascular events (MACE) after coronary interventions, according to a study.

IBD patients who undergo coronary intervention at increased risk of MACE

08 May 2025

Which agents improve histology in EoE?

05 May 2025

Several medications such as orodispersible budesonide (ODB), oral viscous budesonide (OVB), and fluticasone, among others, demonstrate efficacy in the treatment of eosinophilic esophagitis (EoE) in adults and children, according to the results of a network meta-analysis.

Which agents improve histology in EoE?

05 May 2025

Anxiety, depression predict pain, HRQoL in cirrhosis patients

03 May 2025

Pain is prevalent among patients with cirrhosis who are undergoing liver transplant evaluation, a study has found. Anxiety and depression show a significant association with pain and appear to predict poor health-related quality of life (HRQoL) in this population.

Anxiety, depression predict pain, HRQoL in cirrhosis patients

03 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

Progestin-only contraceptives may pose NAFLD risk among women with GDM history

25 Apr 2025 by

The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.

Progestin-only contraceptives may pose NAFLD risk among women with GDM history

25 Apr 2025

Atezolizumab + trastuzumab + XELOX: A promising combination in advanced gastric cancer

20 Apr 2025

Adding atezolizumab to the combination of trastuzumab plus capecitabine and oxaliplatin chemotherapy (XELOX) helps improve treatment response in patients with ERBB2-positive locally advanced resectable gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma, according to the results of the open-label phase II trial conducted in China.

Atezolizumab + trastuzumab + XELOX: A promising combination in advanced gastric cancer

20 Apr 2025

Is it advisable to resume DOAC use 1 day after colorectal ESD?

14 Apr 2025 by

Resumption of direct oral anticoagulants (DOACs) a day after undergoing colorectal endoscopic submucosal dissection (ESD) results in fewer thromboembolic events without elevating the risk of delayed bleeding compared with 2 or 3 days after ESD, reports a study.

Is it advisable to resume DOAC use 1 day after colorectal ESD?

14 Apr 2025

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

13 Apr 2025

Coeliac disease may be safely diagnosed based on clinical features and endomysial antibody testing in low-risk adult patients, according to a study.

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

13 Apr 2025

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

12 Apr 2025 by

The health-related quality of life (QOL) trajectories for colorectal cancer (CRC) patients are largely similar, regardless of whether they received adjuvant chemotherapy, according to a study from Singapore. However, CRC patients who undergo adjuvant treatments commonly experience difficulties with functional recovery.

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

12 Apr 2025

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

Paediatric patients with autoinflammatory diseases undergoing treatment with canakinumab and tocilizumab can be safely vaccinated against hepatitis A, according to a prospective interventional study.

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

IBD patients who undergo coronary intervention at increased risk of MACE

IBD patients who undergo coronary intervention at increased risk of MACE

Which agents improve histology in EoE?

Which agents improve histology in EoE?

Anxiety, depression predict pain, HRQoL in cirrhosis patients

Anxiety, depression predict pain, HRQoL in cirrhosis patients

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Progestin-only contraceptives may pose NAFLD risk among women with GDM history

Progestin-only contraceptives may pose NAFLD risk among women with GDM history

Atezolizumab + trastuzumab + XELOX: A promising combination in advanced gastric cancer

Atezolizumab + trastuzumab + XELOX: A promising combination in advanced gastric cancer

Is it advisable to resume DOAC use 1 day after colorectal ESD?

Is it advisable to resume DOAC use 1 day after colorectal ESD?

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

Noninvasive approach for diagnosing coeliac disease feasible in low-risk adults

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

Adjuvant chemo does not alter QOL trajectory for CRC patients, but functional recovery a challenge

Hepatitis A vaccine may be safely administered to children on biologic therapy

Hepatitis A vaccine may be safely administered to children on biologic therapy